1 – 19 of 19
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Growth pattern of experimental glioblastoma
(
- Contribution to journal › Article
- 2015
-
Mark
A GFP Positive Glioblastoma Cell Line NS1 : A New Tool for Experimental Studies
(
- Contribution to journal › Article
- 2014
-
Mark
Immunization with syngeneic interferon-gamma (IFN-g) secreting tumour cells enhance the Therapeutic effect and Abscopal effect from combined treatment of subcutaneously implanted contra-lateral N29 tumours on Fischer rats with Pulsed electric fields (PEF) and 60Co-gamma radiation.
(
- Contribution to journal › Article
- 2012
-
Mark
Photon activation therapy of RG2 glioma carrying Fischer rats using stable thallium and monochromatic synchrotron radiation.
(
- Contribution to journal › Article
- 2011
-
Mark
“Abscopal” Effect of Radiation Therapy Combined with Immune-Therapy Using IFN-γ Gene Transfected Syngeneic Tumor Cells, in Rats with Bilateral Implanted N29 Tumors
(
- Contribution to journal › Article
- 2010
-
Mark
Radiation immunomodulatory gene tumor therapy of rats with intracerebral glioma tumors.
(
- Contribution to journal › Article
- 2008
-
Mark
Survival of rats with N29 brain tumours after irradiation with 5 or 15 Gy and immunization with IFN-gamma secreting tumour cells
2008) 1st International Conference on Biomedical Engineering and Informatics In BioMedical Engineering and Informatics: New Development and the Future - Proceedings of the 1st International Conference on BioMedical Engineering and Informatics, BMEI 2008 2. p.243-247(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
- 2005
-
Mark
Abscopal effect on subcutaneously implanted N29 rat glioma tumors, from contralateral treatments with pulsed electric fields, radiation therapy, and immunization with syngeneic interferon-gamma-secreting tumor cells
2005) World Federation of Neuro-Oncology Second Quadrennial Meeting and the Sixth Meeting of the European Association for Neuro-Oncology In Neuro-Oncology 7(3). p.398-398(
- Contribution to journal › Published meeting abstract
- 2004
-
Mark
Quality assurance of patient dosimetry in boron neutron capture therapy
(
- Contribution to journal › Article
- 2003
-
Mark
Boron neutron capture therapy for glioblastoma multiforme : Clinical studies in Sweden
(
- Contribution to journal › Article
- 2002
-
Mark
Current status of dosimetry at the boron neutron capture therapy facility at Studsvik, Sweden
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
- 2000
-
Mark
Electroporation--a new possibility in boron neutron capture therapy?
(
- Contribution to journal › Letter
- 1995
-
Mark
A stochastic model for subcellular dosimetry in boron neutron capture therapy
(
- Contribution to journal › Article
-
Mark
Necrosis of malignant gliomas after intratumoral injection of 201Tl in vivo in the rat
(
- Contribution to journal › Article
-
Mark
Performance of sulfhydryl boron hydride in patients with grade III and IV astrocytoma: a basis for boron neutron capture therapy
(
- Contribution to journal › Article
-
Mark
A comparative study on the pharmacokinetics and biodistribution of boronated porphyrin (BOPP) and sulfhydryl boron hydride (BSH) in the RG2 rat glioma model
(
- Contribution to journal › Article
- 1993
-
Mark
Neutron capture imaging of 10B in tissue specimens
(
- Contribution to journal › Article
-
Mark
Beta camera low activity tumor imaging
(
- Contribution to journal › Article
-
Mark
A new brain tumour therapy combining bleomycin with in vivo electropermeabilization
(
- Contribution to journal › Article